Global Pulmonary Drug Delivery Systems Market: Snapshot
Pulmonary drug delivery systems refer to the technologies that are used to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis using pulmonary route of drug administration. While these systems have been in medical use for more than six decades, recent technological advancements in pulmonary drug delivery systems have expanded their potential application in other diseases as well including diabetes, lung cancer, and others. The market for pulmonary drug delivery systems is projected to be worth US$28.7 bn by the end of 2019, propagating at a notable CAGR of 4.4% during the forecast period of 2017 to 2019.
Apart from growing adoption of pulmonary drug delivery as an alternative to route of drug delivery, the market is gaining traction from some of the other factors such as the development of smart and digital inhalers, increasing number of smokers, and growth of the distribution network since the emergence of ecommerce. On the flip side, regulatory hurdles, patent expiration of some of the blockbuster drugs, and issues pertaining to the stability of drugs are some of the restraints hindering the prosperity of the global pulmonary drug delivery systems market. However, the vendors of this market are expected to gain vast new opportunities in the emerging economies of Asia Pacific.
Metered Dore Inhalers Market’s Key Product Segment
On the basis of product type, the pulmonary drug delivery devices market has been segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhaler (DPI). As of 2017, the MDI segment has the maximum demand, providing for a revenue of US$14,512.7 mn. MDIs can be further classified into three categories based on the drugs delivered, namely metered dose inhalers with bronchodilators, corticosteroids, and a combination of both. However, patents of blockbuster drugs such as Advair HFA/Seretide Evohaler and Ventolin HFA/Ventolin Evohaler by GlaxoSmithKline have expired in 2017 and is expected to reflect negatively over the MDI segment. On the other hand, the demand for nebulizers and DPIs have been anticipated multiply profitably during the forecast period of 2017 to 2019.
The report also classifies the pulmonary drug delivery systems market on the basis of application, into COPD, cystic fibrosis, and asthama. The latter provided for a demand worth of US$16,085.9 mn in 2017 and is projected to remain most profitable over the course of next seven years. The analysts of the report have also bifurcated the market on the basis of distribution channel into hospital pharmacies, retail pharmacies, and ecommerce.
Developed and Developing Economies Driving Demand
In terms of region, North America, Europe, and Asia Pacific are the three regions of greatest potential. According to the analysts, the North America pulmonary drug delivery systems market was worth US$10,072.8 mn, gaining traction from factors such as strong prevalence of asthma, consistent focus of the government to reduce treatment costs, and escalating percentage of geriatrics in the U.S. The European market for pulmonary drug delivery systems, which was valued at US$7,059.0 mn in 2017, is driven by the countries of Germany, France, the U.K., Italy, and Spain. Some of the major factors responsible for this stunted growth in Europe include active penetration by generic makers and government austerity measures in key countries to reduce prices. Vastly populated region of Asia Pacific, driven by the emerging economies of China and India, is expected to generate demand for pulmonary drug delivery devices at a robust rate during the forecast period of this report.
AstraZeneca Plc, Novartis AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Merck & Co. Inc., and Teva Pharmaceutical Industries Ltd. are a few key players operating in the global pulmonary drug delivery systems market.
1.Preface
1.1.Report Scope
1.2.Market Segmentation
1.3.Research Highlights
2.Assumptions and Research Methodology
2.1.Assumptions
2.2.Research Methodology
3.Executive Summary
4.Market Overview
4.1.Product Type Overview
4.2.Key Industry Events
4.3.Market Opportunity Map
5.Market Dynamics
5.1.Drivers and Restraints Snapshot Analysis
5.2.Drivers
5.3.Restraints
5.4.Opportunity Analysis
5.5.Opportunities
5.6.Trends
5.7.Porter’s Five Forces Analysis
5.8.Value Chain Snapshot
6.Pulmonary Drugs Market Analysis, by Product Type
6.1.Key Findings
6.2.Introduction
6.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type
6.4.Global Pulmonary Drug Delivery Devices Market Forecast, by Product Type
6.4.1.Global Dry Powder Inhalers (DPIs) Market Revenue (US$ Mn) and Volume (million units), 2014–2024
6.4.2.Global Metered Dose Inhalers (MDIs) Market Revenue (US$ Mn) and Volume (million units), 2014–2024
6.4.3.Global Nebulizers Market Revenue (US$ Mn) and Volume (million units), 2014–2024
6.5.Global Pulmonary Drugs Market Attractiveness Analysis, by Product Type
6.6.Key Trends
7.Pulmonary Drug Delivery Devices Market Analysis, by Application
7.1.Key Findings
7.2.Introduction
7.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Application, 2016 and 2024
7.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and volume (million units) Forecast, By Application, 2014–2024
7.4.1.Global Asthma Market Revenue (US$ Mn) and volume (million units), 2014–2024
7.4.2.Global COPD Market Revenue (US$ Mn) and volume (million units), 2014–2024
7.4.3.Global Cystic Fibrosis Market Revenue (US$ Mn) and volume (million units), 2014–2024
7.4.4.Global Other Applications Market Revenue (US$ Mn) and volume (million units), 2014–2024
7.4.5.Global Pulmonary Drug Delivery Devices Market Attractiveness By Application
7.5.Key Trends
8.Pulmonary Drug Delivery Devices Market Analysis, by Distribution Channel
8.1.Key Findings
8.2.Introduction
8.3.Global Pulmonary Drug Delivery Devices Market Value Share Analysis, By Distribution Channel, 2016 and 2024
8.4.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Distribution Channel, 2015–2024
8.4.1.Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014–2024
8.4.2.Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (million units), 2014–2024
8.4.3.Global E-commerce Market Revenue (US$ Mn) and Volume (million units), 2014–2024
8.5.Global Pulmonary Drug Delivery Devices Market Attractiveness by Distribution Channel
9.Pulmonary Drug Delivery Devices Market Analysis, By Region
9.1.Global Scenario
9.2.Global Pulmonary Drug Delivery Devices Market Value Share Analysis By Region, 2016 and 2024
9.3.Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, By Region, 2016–2024
9.4.Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
10.North America Pulmonary Drug Delivery Devices Market Analysis
10.1.Key Findings
10.2.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
10.3. North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
10.4.North America Market Attractiveness Analysis, by Country
10.5.North America Market Value Share Analysis, by Product Type, 2016 and 2024
10.6.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
10.7.North America Market Value Share Analysis, by Application, 2016 and 2024
10.8.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
10.9.North America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
10.10.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
10.11.North America Market Value Share Analysis, by Country, 2016 and 2024
10.12.North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
10.13.North America Market Attractiveness Analysis, by Product Type
10.14.North America Market Attractiveness Analysis, by Application
10.15.North America Market Attractiveness Analysis, by Distribution Channel
11.Europe Pulmonary Drug Delivery Devices Market Analysis
11.1.Key Findings
11.2.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
11.3. Europe Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
11.4.Europe Market Attractiveness Analysis, by Country
11.5.Europe Market Value Share Analysis, by Product Type, 2016 and 2024
11.6.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
11.7.Europe Market Value Share Analysis, by Application, 2016 and 2024
11.8.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
11.9.Europe Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
11.10.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
11.11.Europe Market Value Share Analysis, by Country, 2016 and 2024
11.12.Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
11.13.Europe Market Attractiveness Analysis, by Product Type
11.14.Europe Market Attractiveness Analysis, by Application
11.15.Europe Market Attractiveness Analysis, by Distribution Channel
12.Asia Pacific Pulmonary Drug Delivery Devices Market Analysis
12.1.Key Findings
12.2.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
12.3. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
12.4.Asia Pacific Market Attractiveness Analysis, by Country
12.5.Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
12.6.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
12.7.Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
12.8.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
12.9.Asia Pacific Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
12.10.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
12.11.Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
12.12.Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
12.13.Asia Pacific Market Attractiveness Analysis, by Product Type
12.14.Asia Pacific Market Attractiveness Analysis, by Application
12.15.Asia Pacific Market Attractiveness Analysis, by Distribution Channel
13.Latin America Pulmonary Drug Delivery Devices Market Analysis
13.1.Key Findings
13.2.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
13.3. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
13.4.Latin America Market Attractiveness Analysis, by Country
13.5.Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
13.6.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
13.7.Latin America Market Value Share Analysis, by Application, 2016 and 2024
13.8.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
13.9.Latin America Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
13.10.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
13.11.Latin America Market Value Share Analysis, by Country, 2016 and 2024
13.12.Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
13.13.Latin America Market Attractiveness Analysis, by Product Type
13.14.Latin America Market Attractiveness Analysis, by Application
13.15.Latin America Market Attractiveness Analysis, by Distribution Channel
14.Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis
14.1.Key Findings
14.2.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, 2016–2024
14.3. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
14.4.Middle East & Africa Market Attractiveness Analysis, by Country
14.5.Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
14.6.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Product Type, 2016–2024
14.7.Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
14.8.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Application, 2016–2024
14.9.Middle East & Africa Market Revenue Share Analysis, by Distribution Channel, 2016 and 2024
14.10.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Distribution Channel, 2016–2024
14.11.Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
14.12.Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (million units) Forecast, by Country, 2016–2024
14.13.Middle East & Africa Market Attractiveness Analysis, by Product Type
14.14.Middle East & Africa Market Attractiveness Analysis, by Application
14.15.Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
15.Competition Landscape
15.1.Global Pulmonary Drugs Market Share Analysis, By Company, (2015)
15.2.Competitive Dashboard
15.3.Pipeline Snapshot
16.Company Profiles
16.1.Boehringer Ingelheim GmbH
16.1.1.Company Overview
16.1.2.Business Overview
16.1.3.Financial Overview
16.1.4.SWOT Analysis
16.1.5.Strategic Overview
16.2.Novartis AG
16.2.1.Company Overview
16.2.2.Business Overview
16.2.3.Financial Overview
16.2.4.SWOT Analysis
16.2.5.Strategic Overview
16.3.GlaxoSmithKline plc
16.3.1.Company Overview
16.3.2.Business Overview
16.3.3.Financial Overview
16.3.4.SWOT Analysis
16.3.5.Strategic Overview
16.4.AstraZeneca plc
16.4.1.Company Overview
16.4.2.Business Overview
16.4.3.Financial Overview
16.4.4.SWOT Analysis
16.4.5.Strategic Overview
16.5.Teva Pharmaceutical Industries Ltd.
16.5.1.Company Overview
16.5.2.Business Overview
16.5.3.Financial Overview
16.5.4.SWOT Analysis
16.5.5.Strategic Overview
16.6.Merck & Co., Inc.
16.6.1.Company Overview
16.6.2.Business Overview
16.6.3.Financial Overview
16.6.4.SWOT Analysis
16.6.5.Strategic Overview
16.7.MannKind Corporation
16.7.1.Company Overview
16.7.2.Business Overview
16.7.3.Financial Overview
16.7.4.SWOT Analysis
16.7.5.Strategic Overview
16.8.F. Hoffmann-La Roche Ltd.
16.8.1.Company Overview
16.8.2.Business Overview
16.8.3.Financial Overview
16.8.4.SWOT Analysis
16.8.5.Strategic Overview
16.9.Bristol-Myers Squibb Company
16.9.1.Company Overview
16.9.2.Business Overview
16.9.3.Financial Overview
16.9.4.SWOT Analysis
16.9.5.Strategic Overview
16.10.Mylan N.V.
16.10.1. Company Overview
16.10.2. Business Overview
16.10.3. Financial Overview
16.10.4. SWOT Analysis
16.10.5. Strategic Overview
16.11.Omron Corporation
16.11.1.Company Overview
16.11.2.Business Overview
16.11.3.Financial Overview
16.11.4.SWOT Analysis
16.11.5.Strategic Overview
16.12.3M Healthcare
16.12.1.Company Overview
16.12.2.Business Overview
16.12.3.Financial Overview
16.12.4.SWOT Analysis
16.12.5.Strategic Overview
16.13.Sunovion Pharmaceuticals, Inc.
16.13.1.Company Overview
16.13.2.Business Overview
16.13.3.Financial Overview
16.13.4.SWOT Analysis
16.13.5.Strategic Overview
16.14.Koninklijke Philips N.V.
16.14.1.Company Overview
16.14.2.Business Overview
16.14.3.Financial Overview
16.14.4.SWOT Analysis
16.14.5.Strategic Overview
16.15.Gerresheimer AG
16.15.1.Company Overview
16.15.2.Business Overview
16.15.3.Financial Overview
16.15.4.SWOT Analysis
16.15.5.Strategic Overview
16.16.Bespak
16.16.1.Company Overview
16.16.2.Business Overview
16.16.3.Financial Overview
16.16.4.SWOT Analysis
16.16.5.Strategic Overview
16.17.AptarGroup, Inc.
16.17.1.Company Overview
16.17.2.Business Overview
16.17.3.Financial Overview
16.17.4.SWOT Analysis
16.17.5.Strategic Overview
16.18.SHL Group
16.18.1. Company Overview
16.18.2. Business Overview
16.18.3. SWOT Analysis
16.18.4. Strategic Overview
16.19.Nypro Healthcare Inc. (Jabil Circuit Inc.)
16.19.1.Company Overview
16.19.2.Business Overview
16.19.3.Financial Overview
16.19.4.SWOT Analysis
16.19.5.Strategic Overview
16.20.Hovione
16.20.1.Company Overview
16.20.2.Business Overview
16.20.3.Financial Overview
16.20.4.SWOT Analysis
16.20.5.Strategic Overview
16.21.Chiesi Farmaceutici S.p.A.
16.21.1.Company Overview
16.21.2.Business Overview
16.21.3.Financial Overview
16.21.4.SWOT Analysis
16.21.5.Strategic Overview
List of Tables
Table 01: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2016–2024
Table 02: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2016–2024
Table 03: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2016–2024
Table 04: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2016–2024
Table 05: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 06: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2014–2024
Table 07: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2016–2024
Table 08: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 09: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2016–2024
Table 10: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2016–2024
Table 11: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2016–2024
Table 12: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 13: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2016–2024
Table 14: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 15: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 16: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 17: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 18: Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 19: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 20: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 21: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 22: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 23: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 24: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 25: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 26: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 27: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 28: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 29: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 30: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 31: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 32: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 33: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 34: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 35: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2016–2024
Table 36: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2016–2024
Table 37: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2016–2024
Table 38: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2016–2024
Table 39: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2016–2024
Table 40: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2016–2024
Table 41: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2016–2024
Table 42: Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country, 2016–2024
List of Figures
Figure 01: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 02: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 03: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 04: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
Figure 05: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 06: Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2015–2024
Figure 07: Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 08: Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 09: Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 11: Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2015–2024
Figure 13: Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 14: Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2014–2024
Figure 15: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type
Figure 16: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
Figure 17: Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 18: Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 19: Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 20: COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 21: Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 22: Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 23: Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 24: Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 25: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
Figure 26: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 27: Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 28: Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 29: Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 31: Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2014–2024
Figure 32: E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2015–2024
Figure 33: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
Figure 34: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2016 and 2024
Figure 35: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
Figure 36: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 37: North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 38: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country
Figure 39: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2016 and 2024
Figure 40: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2016 and 2024
Figure 41: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 42: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product
Figure 44: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
Figure 45: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
Figure 46: Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 47: Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 48: Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country
Figure 49: Europe Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 50: Europe Market Value Share Analysis, by Application, 2016 and 2024
Figure 51: Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 52: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 53: Europe Market Attractiveness Analysis, by Product Type
Figure 54: Europe Market Attractiveness Analysis, by Application
Figure 55: Europe Market Attractiveness Analysis, by Distribution Channel
Figure 56: Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 57: Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country
Figure 58: Asia Pacific Market Attractiveness Analysis, by Country
Figure 59: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 60: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
Figure 61: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 62: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 63: Asia Pacific Market Attractiveness Analysis, by Product Type
Figure 64: Asia Pacific Market Attractiveness Analysis, by Application
Figure 65: Asia Pacific Market Attractiveness Analysis, by Distribution Channel
Figure 66: Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2016–2024
Figure 67: Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 68: Latin America Market Attractiveness Analysis, by Country
Figure 69: Latin America Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 70: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 71: Latin America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 72: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 73: Latin America Market Attractiveness Analysis, by Product Type
Figure 74: Latin America Market Attractiveness Analysis, by Application
Figure 75: Latin America Market Attractiveness Analysis, by Distribution Channel
Figure 76: MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2016–2024
Figure 77: MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2015–2024
Figure 78: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 79: Middle East & Africa Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 80: Middle East & Africa Market Value Share Analysis, by Application, 2016 and 2024
Figure 81: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 82: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: Middle East & Africa Market Attractiveness Analysis, by Product Type
Figure 84: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 85: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 86: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2015)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pulmonary Drug Delivery Devices Market Forecast 2017 - 2019
